Article Information
History
- September 12, 2024.
Article Versions
- Version 1 (September 11, 2024 - 09:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Portia Boakye Okyere1,*,
- Sampson Twumasi-Ankrah2,
- Sam Newton1,
- Samuel Nkansah Darko3,
- Michael Owusu Ansah1,
- Eric Darko4,
- Francis Opoku Agyapong4,
- Hyon Jin Jeon5,
- Yaw Adu-Sarkodie4,
- Florian Marks5,6,7,8 and
- Ellis Owusu-Dabo1
- 1School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- 2Department of Statistics and Actuarial Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- 3Department of Molecular Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- 4Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- 5International Vaccine Institute, Gwanak-ro, Gwanak-gu, Seoul, South Korea
- 6Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
- 7Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany
- 8Madagascar Institute for Vaccine Research (MIVR), University of Antananarivo, Antananarivo, Madagascar
- ↵*Portia Boakye Okyere portiaboky{at}gmail.com